90% of GEROPHARM’s product portfolio are life-saving and essential medicinal products. A good share of these are products for treating endocrine system disorders such as diabetes mellitus.
Diabetes mellitus is a chronic disease characterized by high blood sugar. Given the wide prevalence and rapid growth of the number of patients worldwide, diabetes mellitus is often referred to as a non-infectious epidemic. According to the International Diabetes Federation, in 2021, the number of diabetes patients was as high as 537 million.
Diabetes is most dangerous for its complications such as thrombosis, myocardial infarction, chronic kidney disease, and others. It is therefore very important to raise public awareness of the prevention and diagnostics of the disease, as well as to give support to diabetes patients and their families.
GEROPHARM’s efforts in the field of endocrinology are not limited to developing and producing medicinal products for diabetes management. Over the years, the Company has been engaged in social projects aimed at raising awareness of the disease and reaching out to patients’ and physicians’ communities.
In 2013, the Diabetes in Persons project was launched to tell about real patients' lives with diabetes. Within the project, a number of unique socially focused activities to address the diabetes issue were organized. Currently, the initiative aims at helping diabetes patients and their families, as well as at better disease management.